Carlos Vázquez-Calzada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carlos Vázquez-Calzada has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jesús Valdés
Departamento de Bioquímica, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico
3 shared publications - Elisa Azuara-Liceaga
Programa de Posgraduados en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City 04510, Mexico
2 shared publications - Elmer Joel Millan-Casarrubias
Laboratorio de Sistemas de Diagnóstico y Tratamiento de Cáncer, Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional, Mexico City 07340, Mexico
2 shared publications - Jeni Bolaños
Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico
2 shared publications - Mario Alberto Rodriguez
Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico
2 shared publications - Rigoberto Ortiz-Hernández
Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico
2 shared publications
Latest Publications
- Open Access
PRMT5 Inhibitor EPZ015666 Decreases the Viability and Encystment of Entamoeba invadens
Protein arginine methyltransferase 5 (PRMT5) is an enzyme that produces monomethyl arginine (MMA) and symmetric dimethyl arginine (sDMA), post-translational modifications that regulate several cellular processes, including stage conversion in parasitic protozoans. Entamoeba histolytica, the etiologic agent of human amebiasis, has two stages in its life cycle, the trophozoite, which is the replicative form, and the cyst, corresponding to the infective phase. The study of the molecular mechanisms that regulate differentiation in this parasite has been overdue because of a lack of efficient protocols for in vitro encystment. For this reason, Entamoeba invadens, a parasite of reptiles, has been used as a differentiation model system for the genus. Here, we demonstrated the presence of sDMA in E. invadens, which increases during encystment, and identified the PRMT5 of this microorganism (EiPRMT5). In addition, we performed 3D modeling of this enzyme, as well as its molecular docking with the PRMT5 inhibitor EPZ015666, which predicted the affinity of the drug for the active site of the enzyme. In agreement with these findings, EPZ015666 reduced trophozoite viability and encystment. Therefore, EiPRMT5 is a potential target for inhibiting the spread of amebiasis.
Open AccessPRMT5 Inhibitor EPZ015666 Decreases the Viability and Encystment of Entamoeba invadens
Protein arginine methyltransferase 5 (PRMT5) is an enzyme that produces monomethyl arginine (MMA) and symmetric dimethyl arginine (sDMA), post-translational modifications that regulate several cellular processes, including stage conversion in parasitic protozoans. Entamoeba histolytica, the etiologic agent of human amebiasis, has two stages in its life cycle, the trophozoite, which is the replicative form, and the cyst, corresponding to the infective phase. The study of the molecular mechanisms that regulate differentiation in this parasite has been overdue because of a lack of efficient protocols for in vitro encystment. For this reason, Entamoeba invadens, a parasite of reptiles, has been used as a differentiation model system for the genus. Here, we demonstrated the presence of sDMA in E. invadens, which increases during encystment, and identified the PRMT5 of this microorganism (EiPRMT5). In addition, we performed 3D modeling of this enzyme, as well as its molecular docking with the PRMT5 inhibitor EPZ015666, which predicted the affinity of the drug for the active site of the enzyme. In agreement with these findings, EPZ015666 reduced trophozoite viability and encystment. Therefore, EiPRMT5 is a potential target for inhibiting the spread of amebiasis.
- Open Access
- 7 November 2024
- Published by MDPI AG in Preprints.org
PRMT5 Inhibitor EPZ015666 Decreases Viability and Encystment of Entamoeba invadens
PRMT5 methyltranserase is an enzyme that produces monomethyl arginine (MMA) as well as symmetric dimethyl arginine (sDMA), posttranslational modifications that regulate several cellu-lar processes, including stage conversion in parasitic protozoa. Entamoeba histolytica, the etiologic agent of human amebiasis, has two stages in its life cycle, the trophozoite, which is the replicative form, and the cyst, corresponding to the infective phase. The study of the molecular mechanisms that regulate differentiation in this parasite has been overdue by the lack of efficient protocols for in vitro encystment. For this reason, Entamoeba invadens, a reptile parasite, has been used as a dif-ferentiation model system for the genus. Here, we demonstrated the presence of sDMA in E. in-vadens, which increases during encystment, and identified the PRMT5 protein of this microorgan-ism (EiPRMT5). In addition, we performed 3D modeling of this enzyme, as well as its molecular docking with the PRMT5 inhibitor EPZ015666, which predicted the affinity of the drug for the ac-tive site of the enzyme. In agreement, EPZ015666 reduced trophozoite viability and encystment. Therefore, EiPRMT5 is a potential target for the inhibition of amebiasis spread.
- 7 November 2024
- Published by MDPI AG in Preprints.org
Open AccessPRMT5 Inhibitor EPZ015666 Decreases Viability and Encystment of Entamoeba invadens
PRMT5 methyltranserase is an enzyme that produces monomethyl arginine (MMA) as well as symmetric dimethyl arginine (sDMA), posttranslational modifications that regulate several cellu-lar processes, including stage conversion in parasitic protozoa. Entamoeba histolytica, the etiologic agent of human amebiasis, has two stages in its life cycle, the trophozoite, which is the replicative form, and the cyst, corresponding to the infective phase. The study of the molecular mechanisms that regulate differentiation in this parasite has been overdue by the lack of efficient protocols for in vitro encystment. For this reason, Entamoeba invadens, a reptile parasite, has been used as a dif-ferentiation model system for the genus. Here, we demonstrated the presence of sDMA in E. in-vadens, which increases during encystment, and identified the PRMT5 protein of this microorgan-ism (EiPRMT5). In addition, we performed 3D modeling of this enzyme, as well as its molecular docking with the PRMT5 inhibitor EPZ015666, which predicted the affinity of the drug for the ac-tive site of the enzyme. In agreement, EPZ015666 reduced trophozoite viability and encystment. Therefore, EiPRMT5 is a potential target for the inhibition of amebiasis spread.
- 1 July 2022
- Published by Springer Nature
- Vol. 2514, 53-60
A Three-Dimensional Culture-Based Assay to Detect Early Stages of Vasculogenic Mimicry in Ovarian Cancer Cells
Vasculogenic mimicry is a cellular mechanism in which tumor cells grow and align forming complex three-dimensional (3D) channel-like structures in a hypoxic microenvironment. This phenomenon represents a novel oxygen, nutrient, and blood supply, in a similar way as occurs in classic angiogenesis. Vasculogenic mimicry has been described in numerous clinical tumors including breast, prostate, lung, and ovarian cancers where it is associated with poor prognosis; thus, it is considered as a hallmark of highly aggressive and metastatic tumors. Here, we describe a simple method to model the in vitro formation of three-dimensional cellular networks over Matrigel in SKOV3 ovarian cancer cells representing the early stages of vasculogenic mimicry. Key words Ovarian cancer Three-dimensional culture Vasculogenic mimicry Engelbreth Holm Swarm extracellular matrix extract microRNAs miR-765
- 1 July 2022
- Published by Springer Nature
- Vol. 2514, 53-60
A Three-Dimensional Culture-Based Assay to Detect Early Stages of Vasculogenic Mimicry in Ovarian Cancer Cells
Vasculogenic mimicry is a cellular mechanism in which tumor cells grow and align forming complex three-dimensional (3D) channel-like structures in a hypoxic microenvironment. This phenomenon represents a novel oxygen, nutrient, and blood supply, in a similar way as occurs in classic angiogenesis. Vasculogenic mimicry has been described in numerous clinical tumors including breast, prostate, lung, and ovarian cancers where it is associated with poor prognosis; thus, it is considered as a hallmark of highly aggressive and metastatic tumors. Here, we describe a simple method to model the in vitro formation of three-dimensional cellular networks over Matrigel in SKOV3 ovarian cancer cells representing the early stages of vasculogenic mimicry. Key words Ovarian cancer Three-dimensional culture Vasculogenic mimicry Engelbreth Holm Swarm extracellular matrix extract microRNAs miR-765